These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3134266

  • 1. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
    Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A.
    Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
    [Abstract] [Full Text] [Related]

  • 2. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.
    Lanza FL.
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):131S-136S. PubMed ID: 3080285
    [Abstract] [Full Text] [Related]

  • 3. Protective effects against alcohol insult: does somatostatin play any role?
    Agrawal NM, Godiwala T, Arimura A, Groot K, Dajani E.
    Postgrad Med J; 1988 Feb; 64 Suppl 1():15-20. PubMed ID: 2901743
    [Abstract] [Full Text] [Related]

  • 4. Misoprostol versus cimetidine in tolmetin-induced mucosal injury.
    Wallin BA, Frank WO, Young MD.
    Gastroenterology; 1989 May; 96(5 Pt 1):1374-6. PubMed ID: 2495235
    [No Abstract] [Full Text] [Related]

  • 5. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 May; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 6. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F, Peace K, Gustitus L, Rack MF, Dickson B.
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [Abstract] [Full Text] [Related]

  • 7. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage. A double-blind endoscopic study in human subjects.
    Agrawal NM, Godiwala T, Arimura A, Dajani EZ.
    Gastrointest Endosc; 1986 Apr; 32(2):67-70. PubMed ID: 3086177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study.
    Jiranek GC, Kimmey MB, Saunders DR, Willson RA, Shanahan W, Silverstein FE.
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D.
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of misoprostol and cimetidine in the treatment of acute duodenal ulcer. Results of major studies.
    Mazure PA.
    Am J Med; 1987 Jul 27; 83(1A):22-6. PubMed ID: 3113242
    [Abstract] [Full Text] [Related]

  • 12. Overview of the mucosal protective effects of misoprostol in man.
    Dajani EZ.
    Prostaglandins; 1987 Jul 27; 33 Suppl():117-29. PubMed ID: 3122272
    [Abstract] [Full Text] [Related]

  • 13. [Misoprostol and cimetidine in the treatment of active duodenal ulcer. Multicenter, double-blind, clinico-endoscopic study. The Argentine experience].
    Baccaro JC, González del Solar C, Laudanno O, Mauro E, Mazure PA, Pardo R, Pulpeiro A, Rubio H, Tomatis H.
    Acta Gastroenterol Latinoam; 1987 Jul 27; 17(3):235-40. PubMed ID: 3145665
    [Abstract] [Full Text] [Related]

  • 14. Comparison of misoprostol and cimetidine in the treatment of gastric ulcer.
    Fich A, Goldin E, Zimmerman J, Ligumsky M, Rachmilewitz D.
    Isr J Med Sci; 1985 Dec 27; 21(12):968-72. PubMed ID: 3937820
    [Abstract] [Full Text] [Related]

  • 15. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
    Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, Nissen C, Geis S.
    Am J Gastroenterol; 1989 Jun 27; 84(6):633-6. PubMed ID: 2499187
    [Abstract] [Full Text] [Related]

  • 16. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients.
    Nicholson PA.
    Dig Dis Sci; 1985 Nov 27; 30(11 Suppl):171S-177S. PubMed ID: 3932051
    [Abstract] [Full Text] [Related]

  • 17. Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers.
    Shield MJ.
    Dig Dis Sci; 1985 Nov 27; 30(11 Suppl):178S-184S. PubMed ID: 3932052
    [Abstract] [Full Text] [Related]

  • 18. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD, Lambert R, Capron MH.
    Rev Rhum Ed Fr; 1994 Feb 27; 61(2):126-31. PubMed ID: 7920500
    [Abstract] [Full Text] [Related]

  • 19. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.
    Rachmilewitz D, Chapman JW, Nicholson PA.
    Dig Dis Sci; 1986 Feb 27; 31(2 Suppl):75S-80S. PubMed ID: 3080293
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG.
    Am J Gastroenterol; 1991 Dec 27; 86(12):1743-8. PubMed ID: 1962619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.